問卷

TPIDB > Search Result

Search Result

篩選

Study Statistics

5576Cases

20022027

Total

5576

  • I

    615

  • I/II

    269

  • II

    1305

  • II/III

    138

  • III

    2775

  • IV

    109

  • Others

    363

List

5576Cases

2020-07-01 - 2022-05-01

Phase I/II

Completed
A Phase 1, Open-label, Multicenter, Safety Study of SAR442720 in Combination With Pembrolizumab in Patients With Advanced Malignancies
  • Condition/Disease

    Advanced Malignancies

  • Test Drug

    SAR442720

Participate Sites
2Sites

Recruiting2Sites

2021-12-01 - 2024-12-31

Phase II

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Recruiting3Sites

2021-01-31 - 2024-04-30

Phase II

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Terminated4Sites

2021-06-20 - 2025-12-31

Phase I

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Recruiting2Sites

Terminated2Sites

2021-02-01 - 2024-12-31

Phase II

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Terminated3Sites